A volunteer dies who participated in Oxford vaccine tests

A volunteer from Brazil who participated in tests of an anti vaccine CO VID-19, developed by AstraZeneca and Oxford University, has died in the third phase of a clinical test of the vaccine, the Brazilian state health regulatory agency Anvisa confirmed. Oxford University announced that he did not receive the vaccine, but a placebo, who wants [...]
Oxford University announced that he did not receive the vaccine, but a placebo, meaning that he did not die from the effects of the vaccine.
After the volunteer's death, Oxford announced that the volunteer was part of the control group and that instead of the coronary vaccine, he took it against meningitis.
Brazilian health regulator announced that the development of the vaccine will continue despite volunteer deaths, Reuters reports.
They also said they were informed of the volunteer's death on October 19th, but due to ethics and privacy, in accordance with national and international regulations, data for clinical test volunteers must be kept secret.
The federal university in São Paulo confirmed the volunteer's death in a separate statement, suggesting that he was a Brazilian citizen.
Oxford University reported that an independent body had confirmed that the accident was not a side effect of the vaccine and that the investigation is continuing.
After careful analysis of this case in Brazil, there is no reason to worry about the security of clinical trials and an independent body, such as Brazilian authorities, has advised the testing to continue”, a university spokesman said.











